Work

A Phase Ib/II Study of Combined Obinutuzumab (Gazyva) and High-Dose Methylprednisolone (HDMP) As Treatment for Patients with Chronic Lymphocytic Leukemia (CLL)

Year: 2016

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v128.22.2051.2051

Authors: Januario E. Castro, Michael Y. Choi, Carlos I. Amaya-Chanaga, Natalie Nguyen, Colin MacCarthy, Thomas J. Kipps

Institutions: University of California San Diego, Moores Cancer Center

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2556182682

FWCI: 0.408

Cites:

Cited by: 3

Related to: 10